DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2247400/pharma-stock-roundup-abbv-nvo-s-new-m-as-fda-nod-to-jnj-mrk-pah-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-2247400 Mar 28, 2024 - While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves J&J's (JNJ) and Merck's (MRK) PAH drugs. 0

https://www.zacks.com/stock/news/2245659/abbvie-abbv-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2245659 Mar 25, 2024 - AbbVie (ABBV) closed at $178.53 in the latest trading session, marking a +0.04% move from the prior day. 0

https://www.zacks.com/stock/news/2245594/why-abbvie-abbv-is-a-great-dividend-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2245594 Mar 25, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out. 0

https://www.zacks.com/commentary/2242883/top-analyst-reports-for-mastercard-abbvie-salesforce?cid=CS-ZC-FT-research_daily-2242883 Mar 19, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), AbbVie Inc. (ABBV) and Salesforce, Inc. (CRM). 0

https://www.fool.com/investing/2024/03/09/the-ai-race-gets-litigious/?source=iedfolrf0000001 Mar 09, 2024 - We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade. 0

https://www.zacks.com/stock/news/2238174/why-abbvie-abbv-is-a-top-dividend-stock-for-your-portfolio?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2238174 Mar 08, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out. 0

https://www.zacks.com/stock/news/2229455/abbvie-abbv-announces-appointment-of-new-ceo-robert-michael?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2229455 Feb 21, 2024 - Robert Michael is set to succeed Richard A. Gonzalez as AbbVie's (ABBV) CEO, effective Jul 1, 2024. 0

https://www.fool.com/investing/2024/02/19/3-magnificent-growth-stocks-to-buy-right-now/?source=iedfolrf0000001 Feb 19, 2024 - These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. 0

https://www.zacks.com/stock/news/2227354/ironwood-irwd-q4-earnings-miss-revenues-beat-marginally?cid=CS-ZC-FT-analyst_blog|earnings_article-2227354 Feb 16, 2024 - Ironwood's (IRWD) fourth-quarter 2023 earnings lag estimates while revenues beat the same marginally. Linzess collaboration revenues drive the top line. 0

https://www.zacks.com/commentary/2224591/top-stock-reports-for-abbvie-applied-materials-american-express?cid=CS-ZC-FT-research_daily-2224591 Feb 12, 2024 - Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Applied Materials, Inc. (AMAT) and American Express Company (AXP). 0